1. WHO Coronavirus disease 2019 (COVID-19) situation report – 66. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200326-sitrep-66-covid-19.pdf?sfvrsn=81b94e61_2. Published March 26, 2020. Accessed March 27, 2020.
2. Gianotti G. I'm a doctor at Italy’s hardest-hit hospital. I had to decide who got a ventilator and who didn’t. https://www.abc.net.au/news/2020-03-27/coronavirus-doctor-cremona-hospital-decide-who-lives-and-dies/1209091Published March 27, 2020. Accessed March 27, 2020.
3. Chinese Clinical Trial Registry: A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19). http://www.chictr.org.cn/showprojen.aspx?proj=49409.
4. ClinicalTrials.gov: Tocilizumab in COVID-19 Pneumonia (TOCIVID-19). https://www.clinicaltrials.gov/ct2/show/NCT04317092.
5. Conti P, Ronconi G, Caraffa A, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020 Mar 14;34(2). pii: 1. doi: 10.23812/CONTI-E. [Epub ahead of print].